Another trial, which included the administration of calcitriol using 0.5 μg two times a week for a length of 12 consecutive years, in 10 patients resulted in a major reduction of the urine albumin to creatinine ratio, proved by IgA nephropathy. The gene discussed is ALB; the disease is IgA glomerulonephritis.